GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Stock Based Compensation

Dr. Lal PathLabs (NSE:LALPATHLAB) Stock Based Compensation : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Stock Based Compensation?

Dr. Lal PathLabs's Stock Based Compensation for the three months ended in Mar. 2024 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Dr. Lal PathLabs Stock Based Compensation Historical Data

The historical data trend for Dr. Lal PathLabs's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Stock Based Compensation Chart

Dr. Lal PathLabs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 166.37 203.74 323.00 228.11 217.06

Dr. Lal PathLabs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dr. Lal PathLabs Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Dr. Lal PathLabs Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Stock Based Compensation
Comparable Companies
BOM:542650 BOM:543350 NSE:THYROCARE BOM:543328 BOM:524394 BOM:526546 BOM:540788 BOM:540729 BOM:539267 BOM:526301 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
539524:India
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Website
https://www.lalpathlabs.com
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines